Starling Oncology STLNW SEC Filings

NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Starling Oncology, Inc. (STLNW) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index